Posts

Showing posts from July, 2024

Reduced Cost Sharing and Medication Management Services for COPD

This randomized clinical trial examines the effect of a national program to reduce beneficiary cost sharing for chronic obstructive pulmonary disease (COPD) maintenance inhalers and provide medication management services that included education on proper technique for inhaler use. from JAMA Internal Medicine Online First https://ift.tt/lKNOgUZ

The CREATE TRUST Communication Framework for Patient Messaging Services

This Viewpoint proposes a messaging framework called CREATE TRUST to improve written communication with patients. from JAMA Internal Medicine Online First https://ift.tt/JjVKaLD

Reforming 340B to Serve the Interests of Patients, Not Institutions

This Viewpoint discusses reforms to the 340B Drug Pricing Program to focus revenues from the program on lower-income and uninsured patients. from JAMA Health Forum New Online https://ift.tt/chDEJ5S

The Role of Individual Coverage Health Reimbursement Arrangements—The Liger of Health Insurance?

This JAMA Forum discusses aspects of individual coverage health reimbursement arrangements and their expanded use over the last few years. from JAMA Health Forum New Online https://ift.tt/w0gXTPU

Can Artificial Intelligence Speak for Incapacitated Patients at the End of Life?

This Viewpoint examines how artificial intelligence could support surrogate decision-makers while addressing some of the attendant epistemic and moral challenges. from JAMA Internal Medicine Online First https://ift.tt/9UYwe8H

State Spending Targets for Prescription Drugs

This Viewpoint discusses the limitations of state prescription drug spending targets for lowering medication costs. from JAMA Health Forum New Online https://ift.tt/g9PUnWD

Data on the US Economy—A Model for Health Data?

This JAMA Forum discusses 3 key steps for restructuring the acquisition of health data to enable more timely access to the data and more timely public health action, similar to the successes seen with the COVID-19 pandemic response in the US. from JAMA Health Forum New Online https://ift.tt/EYeJvnO

Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany

This Viewpoint compares use and costs of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss between the US and 3 other peer countries. from JAMA Internal Medicine Online First https://ift.tt/KYo2PVn

Errors in a Table and Figure

Health Policy from JAMA Health Forum New Online https://ift.tt/leOW8nQ

Use of Medications for Opioid Use Disorder and Child Welfare Outcomes

This cohort study investigates whether use of medications for opioid use disorder in pregnancy is associated with higher rates of infants discharge home with their mothers after birth. from JAMA Health Forum New Online https://ift.tt/iZL5ekP

Mortality Disparities Among Arrestees by Race, Sentencing Disposition, and Place

This population-based observational study assesses disparities in mortality risk between American Indian/Alaska Native and White arrestees in South Dakota from 2000 to 2016. from JAMA Health Forum New Online https://ift.tt/W8Mjbmp

Behavioral Economics to Enhance Food Is Medicine Programs

This Viewpoint highlights ways in which behavioral economics could enhance Food Is Medicine programs in the US. from JAMA Health Forum New Online https://ift.tt/gVzN6MI

Congress Must Update FDA Regulations for Medical AI

This JAMA Forum discusses pending legislation in the US House and Senate and the history of the “firm-based approach” the US Food and Drug Administration (FDA) could use when regulating artificial intelligence (AI) medical devices to augment patient care. from JAMA Health Forum New Online https://ift.tt/3VOCdsn

Alternative Payment Models and Performance in Federally Qualified Health Centers

This cohort study examines whether Medicaid alternative payment models are associated with the health care quality, health outcome measures, payer mix, and risk profile of federally qualified health centers. from JAMA Internal Medicine Online First https://ift.tt/4mnjgyi

Essential Care for Women Experiencing Intimate Partner Violence

This Viewpoint describes essential health care services for women experiencing intimate partner violence and strategies for providing these services during disasters and public health emergencies. from JAMA Internal Medicine Online First https://ift.tt/cUlfepY

Scaling the CMS Cardiovascular Risk Reduction Model

This Viewpoint discusses the potential benefits of expanding the Million Hearts Cardiovascular Risk Reduction Model of the US Centers for Medicare & Medicaid Services (CMS). from JAMA Health Forum New Online https://ift.tt/NpQ25gk

Preventive Effect of Neuromuscular Training on Chemotherapy-Induced Neuropathy

This randomized clinical trial assesses whether sensorimotor training and whole-body vibration training reduce symptoms and decrease the onset of chemotherapy-induced peripheral neuropathy. from JAMA Internal Medicine Online First https://ift.tt/WUTCl7R